Dr. Wagdy William Kades, MD

Dr. Kades practices at Wagdy Kades MD in Los Angeles, California.

Dr. Kades' NPI, 1326080060, was assigned on June 10, 2006. Dr. Kades graduated from University of Alexandria Faculty of Medicine in 1988. Dr. Kades holds California license A56293.

Dr. Kades' primary practice is Wagdy Kades MD, at 1245 Wilshire Blvd Ste 775, Los Angeles, CA 90017-4881. The practice phone is (213) 484-5397.

Dr. Kades' primary practice is Wagdy Kades MD in Los Angeles, California. Dr. Kades is also affiliated with PIH Health Good Samaritan Hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Kades practices, 2 sites in all. Vendor and product names are available with a free account.

Rheumatology is Dr. Kades' primary specialty in the NPI Registry, under taxonomy code 207RR0500X. Dr. Kades is board certified in internal medicine by the American Board of Internal Medicine. Dmand AI has Dr. Kades' licenses on file in 2 states: California and New Mexico.

Dmand AI lists arteritis, arthritis, fibromyalgia and chronic pain, fluid in a joint, gout, joint pain, lupus and muscle pain, fibromyalgia, and limb pain among the conditions Dr. Kades treats.

CMS data shows 3,231 Medicare services from Dr. Kades across 12 procedure codes in 2024, for 348 Medicare patients. Medicare paid $134,862 for them. Every service was in an office.

CMS counts 348 Medicare patients who saw Dr. Kades in 2024. The largest group is 65 to 74, with 141 patients. 75% of them have arthritis, and 75% have high blood pressure. 84% are also on Medicaid. Their average risk score is 1.64, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Kades' median patient age at 58, with 83% women.

In 2024, Dr. Kades wrote 6,160 Medicare Part D claims for 798 patients. 88% of them were for generic drugs. CMS names the drug for 6,001 of them, across 55 drugs with 11 or more claims each, at $2,348,257 in total drug cost. In 2023, CMS named 6,091 claims across 52 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Kades for performance year 2024, reported as part of a group. Dr. Kades accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links Dr. Kades to 1 clinical trial. Conditions studied include Lupus Erythematosus, Systemic and Connective Tissue Diseases.

CMS Open Payments shows 2,077 general payments to Dr. Kades from 48 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 68% of the total. GlaxoSmithKline, LLC. paid the most, $9,794.

Dmand AI lists 2 awards for Dr. Kades, most recently CMS Stage 1 2012 in 2011.

Dr. Kades graduated from University of Alexandria Faculty of Medicine in 1988. Dr. Kades is a member of ACP, ACR and AIUM.

Dr. Kades is in network with 9 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Humana. Medicare plans come from the most carriers, 9. Check the plan with the practice before a visit.